Get 20% lifetime commission for referring investors to digrin.com
here.
4D Molecular Therapeutics, Inc. ( FDMT) - Stock Earnings
FDMT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
FDMT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 19.4 million USD | 85.1 million USD |
| 2026Q1 | -68.8 million USD | 3.0 million USD |
| 2026Q2 | -72.9 million USD | 3.8 million USD |
| 2026Q4 Est. | — | — |
FDMT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.8 million USD | 20.7 million USD |
| 2024 | -160.9 million USD | 37000 USD |
| 2025 | -140.1 million USD | 85.2 million USD |
| 2026 Est. | — | — |
FDMT
Price: $12.14
52 week price:
Earnings Per Share: -2.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 192795
Market Capitalization: 667.8 million